Search

Your search keyword '"Kelley, Colleen F"' showing total 364 results

Search Constraints

Start Over You searched for: Author "Kelley, Colleen F" Remove constraint Author: "Kelley, Colleen F"
364 results on '"Kelley, Colleen F"'

Search Results

1. Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 20211

2. HPTN 083‐02: factors influencing adherence to injectable PrEP and retention in an injectable PrEP study

4. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.

5. The Comparability of Men Who Have Sex With Men Recruited From Venue-Time-Space Sampling and Facebook: A Cohort Study

6. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

8. Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

9. Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials

10. Risk of COVID-19 after natural infection or vaccination

11. “Cure” Versus “Clinical Remission”: The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication

12. Corrigendum to – “Single oral dose for HIV pre or post-exposure prophylaxis: user desirability and biological efficacy in macaques” [eBioMedicine 58(2020) 102894]

13. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

14. Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial

15. Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV.

16. Early Tecovirimat Treatment for Mpox Disease Among People With HIV

17. 2896. Oral PrEP Uptake among HVTN 704/HPTN 085 Participants: Implications for the Future of Biomedical HIV Prevention Trials

18. Associations between HIV and Severe Mpox in an Atlanta Cohort

20. Associations Between HIV and Severe Mpox in an Atlanta Cohort.

21. Risk of COVID-19 after natural infection or vaccination

27. Lack of health insurance is associated with delays in PrEP initiation among young black men who have sex with men in Atlanta, US: a longitudinal cohort study

30. HIV, asymptomatic STI, and the rectal mucosal immune environment among young men who have sex with men

32. "Do We Stay or Do We Go?" The Impact of Anti-LGBTQ+ Legislation on the HIV Workforce in the South.

33. Repeated rectal application of a hyperosmolar lubricant is associated with microbiota shifts but does not affect PrEP drug concentrations: results from a randomized trial in men who have sex with men

34. Severe Acute Respiratory Syndrome Coronavirus 2 Evolution and Escape From Combination Monoclonal Antibody Treatment in a Person With HIV

39. Pharmacology of boosted and unboosted integrase strand transfer inhibitors for two-dose event-driven HIV prevention regimens among men

43. C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 'LIVE-AIR' trial.

46. The association between comorbidities and coronavirus disease 2019 hospitalization among people with HIV differs by age

48. C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 ‘LIVE-AIR’ trial

49. Coronavirus Disease 2019 (COVID-19) Vaccines and Pregnancy

Catalog

Books, media, physical & digital resources